CLN — Celon Pharma SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Celon Pharma SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.

	2019 December 31st	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	Interim Report	ARS	ARS	ARS
Standards:	PAS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	66.7	44	228	165	115
Net Total Accounts Receivable
Net Total Receivables	45.5	41	27.2	33.7	48.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	144	119	279	238	190
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	243	331	329	342	334
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	591	532	707	643	569
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	26	114	86.4	116	86.3
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	146	187	153	163	124
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	445	345	554	480	446
Total Liabilities & Shareholders' Equity	591	532	707	643	569
Total Common Shares Outstanding